Flexibility using single-use System
Business Overview
SK bioscience has established a broad product portfolio and continues to invest in vaccine research,
which will be the driving force in the life science business in the future.
SK bioscience will develop premium vaccines based on superb technology and contribute promoting public health and contribute to the promotion of public health.
which will be the driving force in the life science business in the future.
SK bioscience will develop premium vaccines based on superb technology and contribute promoting public health and contribute to the promotion of public health.
Speed of Execution with Quality
SKYVAX Program
SK bioscience's proprietary product supply to
developing countries including LMIC
Platform Technology
- - Contractual development & manufacturing service
- - Technology transfer to local manufacture including
Manufacturing Versatility
Out-licensing and co-development
for US and Europe market for next decade
Market Leading Sales
/ Marketing Infrastructure
/ Marketing Infrastructure
- Joint sales and consignment production
based on leading position
in domestic vaccine market
Share Innovation
Business field
Process development
R&D center
- Various platform technologies for diverse vaccine types
- Process development team
- Evaluation/analysis team
- Bacterial vaccine team
- Viral vaccine team
- New project team
Development & commercial manufacturing
L HOUSE
- Pioneer in successful adaptation of ‘single-use system’ for vaccines on commercial scale
- ‘Multi-modular system’ for diverse vaccine types
-
-
Diverse platforms
-
Future expansion
Professional sales/marketing
Professional
- Specialized sales/marketing infrastructure make the company as a leader in the domestic vaccine market
- Various consignment production systems improve the convenience of vaccination
-
Unified system from licensing to selling
-
Specialized strategies for public/private market
-
Portfolio for all ages,
from infants to elderly